SEARCH

SEARCH BY CITATION

References

  • 1
    Mettlin C, Lee F, Drago J, Murphy GP. and the members of the American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer 1991; 67: 294958.
  • 2
    Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 115661.
  • 3
    Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, et al. Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 1992; 147: 84651.
  • 4
    Cooner WH, Mosley BR, Rutherford CL Jr, Beard JN, Pond HS, Terry WJ, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990; 143: 114654.
  • 5
    Babaian RJ, Mettlin C, Kane R, Murphy GP, Lee F, Drago J, et al. The relationship of prostate specific antigen to digital rectal examination and transrectal ultrasonography in detecting adenocarcinoma of the prostate. Cancer 1992; 69: 1195200.
  • 6
    Kane RA, Littrup PJ, Babaian R, Drago JR, Lee F, Chesley A. Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Cancer 1992; 69: 12017.
  • 7
    Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147: 81516.
  • 8
    Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of agespecific reference ranges. JAMA 1993; 270: 8604.
  • 9
    Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992; 267: 221520.
  • 10
    Jones EA, Brawer MK. Prostate-specific antigen density and velocity measurements in the diagnosis of prostate cancer. Curr Opin Urol 1993; 3: 37780.
  • 11
    Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 90723.
  • 12
    Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, et al. Characteristics of prostate cancers detected in a multimodality early detection program. Cancer 1993; 72: 17018.
  • 13
    BeahrsOH, HensonDE, HutterRVP, KennedyBJ, editors. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott Co, 1992: 1856.
  • 14
    Mettlin C, Jones G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society Guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin 1993; 43: 426.